Publications

2013

Zhao Q, Zhao Z, Leung-Pineda V, Wiley CL, Nelson PJ, Grenache DG, et al. Predicting respiratory distress syndrome using gestational age and lamellar body count. Clin Biochem. 2013;46(13-14):1228-32.
Wander SA, Zhao D, Besser AH, Hong F, Wei J, Ince TA, et al. PI3K/mTOR inhibition can impair tumor invasion and metastasis in vivo despite a lack of antiproliferative action in vitro: implications for targeted therapy. Breast Cancer Res Treat. 2013;138(2):369-81.
Boiocchi L, Espinal-Witter R, Geyer JT, Steinhilber J, Bonzheim I, Knowles DM, et al. Development of monocytosis in patients with primary myelofibrosis indicates an accelerated phase of the disease. Mod Pathol. 2013;26(2):204-12.
Zou W, Greenblatt MB, Brady N, Lotinun S, Zhai B, de Rivera H, et al. The microtubule-associated protein DCAMKL1 regulates osteoblast function via repression of Runx2. J Exp Med. 2013;210(9):1793-806.
Lunardi A, Ala U, Epping MT, Salmena L, Clohessy JG, Webster KA, et al. A co-clinical approach identifies mechanisms and potential therapies for androgen deprivation resistance in prostate cancer. Nat Genet. 2013;45(7):747-55.
Penney KL, Stampfer MJ, Jahn JL, Sinnott JA, Flavin R, Rider JR, et al. Gleason grade progression is uncommon. Cancer Res. 2013;73(16):5163-8.
Liu Z, Zanata SM, Kim J, Peterson MA, Di Vizio D, Chirieac LR, et al. The ubiquitin-specific protease USP2a prevents endocytosis-mediated EGFR degradation. Oncogene. 2013;32(13):1660-9.
Zhang Y, Shin SJ, Liu D, Ivanova E, Foerster F, Ying H, et al. ZNF365 promotes stability of fragile sites and telomeres. Cancer Discov. 2013;3(7):798-811.
Tsui JF, Weinberger JM, Kashan M, Weiss JP, Robinson BD, Blaivas JG. Bladder lipoma. J Urol. 2013;190(4):1387-8.

Pathology & Laboratory Medicine 1300 York Avenue New York, NY 10065 Phone: (212) 746-6464
Surgical Pathology: (212) 746-2700